Acute Immunological Effects of Exercise in Cancer Patients
Launched by UNIVERSITÄT DUISBURG-ESSEN · Dec 12, 2022
Trial Information
Current as of July 12, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how exercise affects the immune system in cancer patients. Researchers want to see how a single session of exercise compares between those undergoing cancer treatment and healthy individuals of the same age. The study is currently recruiting participants who are adolescents and young adults over the age of 14 and are receiving chemotherapy. To join, participants need to be able to follow instructions and sign consent, but those with certain health issues or recent chemotherapy treatments may not be eligible.
If you or someone you know qualifies for this trial, you can expect to take part in a specific exercise program while having your immune response monitored. This research could help us understand how exercise might benefit cancer patients during treatment. It’s a chance to contribute to important findings in cancer care and possibly improve health outcomes for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescents and young adults \>14 years of age
- • undergoing acute cancer treatment (chemotherapy)
- • signed informed consent
- Exclusion Criteria:
- • Inability to follow and implement test instructions
- • medical contraindication to HIIT on cycle ergometer
- • chemotherapeutic treatment 48 h prior
- • Hb \<8g/dl; platelets \< 20,000/ul.
About Universität Duisburg Essen
The Universität Duisburg-Essen is a prominent academic institution in Germany, renowned for its commitment to research and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, the university leverages its interdisciplinary expertise and state-of-the-art facilities to advance clinical research initiatives. With a focus on improving patient outcomes, the university actively collaborates with healthcare professionals, industry partners, and regulatory bodies to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Through its dedication to enhancing clinical knowledge and fostering new therapeutic approaches, Universität Duisburg-Essen plays a pivotal role in the evolution of modern healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Essen, Nrw, Germany
Patients applied
Trial Officials
Miriam Götte, Dr.
Principal Investigator
University Hospital, Essen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials